[Date Prev][Date Next] [Thread Prev][Thread Next] [Date Index] [Thread Index]

Scott P. Serota to deliver Opening Address of WIN 2014 Symposium



 

Mr. Scott P. Serota, President and CEO of Blue Cross and Blue Shield Association, will deliver the Opening Address of the WIN 2014 Symposium on personalized cancer medicine, to be held in Paris on June 23 and 24.

The WIN 2014 Symposium is the first event worldwide entirely dedicated to innovative combinations of molecularly targeted therapeutics for cancer care.

WIN Symposia are an initiative of the WIN Consortium, a non-profit global collaboration of academic, industry, health plan, and advocacy organizations dedicated to bringing the most promising advances in personalized cancer medicine to patients worldwide. Blue Cross and Blue Shield Association joined the WIN Consortium as a member in 2013.

Mr. Serota will join prestigious leaders at the symposium, who will present keynote lectures during the Symposium, including:

· Robert Weinberg, Cambridge, MA (USA)

· René Bernards, Amsterdam (Netherlands)

· Hans Clevers, Utrecht (Netherlands)

· Leroy Hood, Seattle (USA)

· Guido Kroemer, Villejuif (France)

· Bob Löwenberg, Rotterdam (Netherlands)

· Stefan Pfister, Heidelberg (Germany)

Don’t miss this unique opportunity to interact directly with the world’s leaders in innovations in cancer patient management. Registration and abstract submission are open.  


Blue Cross and Blue Shield Association is a federation of 37 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide healthcare coverage for nearly 100 million members. Scott P. Serota has served Blue Cross and Blue Shield Association as President and CEO since 2000. His health plan perspectives will provide a vital link between the scientific innovations presented by prestigious leaders at the WIN 2014 Symposium and the care received by cancer patients in daily practice

Innovation in therapeutics and active cooperation between stakeholders involved in delivering care to patients is needed to effectively drive efficacy and quality improvement in the area of cancer care, in a realistic societal and economic model.
         - Scott P. Serota -

“The scientific program will address major developments in precision cancer medicine in sessions featuring the world’s leaders in basic and clinical cancer research, each session focusing on the rationale for combinations.”
         
- Pr. Alexander Eggermont, Chair WIN 2014 Symposium -

Click here to view the detailed WIN 2014 program with all lecture title s and speakers names.

 


Symposium Committee Chairs

      - Alexander Eggermont, France
- Gerald Batist, Canada  
- Michael Pellini, USA




WIN 2014 Secretariat
Congress by design
win@congressbydesign.com
www.winsymposium.org

 





Venue
Marriott Rive Gauche
Hotel & Conference Centre
17, Boulevard Saint Jacques
Paris, France


  

 

 


WIN Consortium
Catherine Bresson
Director Operational Team
Catherine.Bresson@winconsortium.org
www.winconsortium.org 

--------------------------------------
To unsubscribe from this mailing list, please click here

Reply to: